Select your timezone:

Organoids and Organ Engineering

Friday September 24, 2021 - 21:00 to 22:15

Room: General Session

200.4 Stem cell-derived organoids for cell replacement therapy and drug screening – an industrial perspective

Camilla Ingvorsen, Denmark

Senior Scientist
Stem Cell R&D
Novo Nordisk A/S